EUVIMEDEUVIMED entdecken
Crossref

Advancing Genotoxicity Assessment by Building a Global AOP Network

E Demuynck iD, T Vanhaecke iD, A Thienpont iD, D Cappoen iD, F Van Goethem iD, L M T Winkelman iD, J B Beltman iD, S Murugadoss iD, A-K Olsen iD, F Marcon iD, C Bossa iD, S M Shaikh iD und 8 weitere

Environmental and Molecular Mutagenesis · 2025

DOI: 10.1002/em.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental and Molecular Mutagenesis, 2025. Verfasst von E Demuynck und 19 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Direction of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium. Hauptthemen laut MEDLINE: Adverse Outcome Pathways, Mutagens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 216 Literaturangaben. Gefördert von: The European Partnership for the Assessment of Risks from Chemicals (PARC), European Union's Horizon Europe Research and Innovation Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current genotoxicity testing strategies face several challenges, including a high incidence of misleading positive results that lead to unnecessary animal testing, limited mechanistic insights, insufficient integration of innovative methodologies, and a lack of quantitative assessment. Despite rapid advancements in technology and scientific understanding, genotoxicity testing batteries have remained largely unchanged for years. To modernize genotoxicity assessment and incorporate innovative approaches, the development of Integrated Approaches for Testing and Assessment (IATAs) is essential. These frameworks combine existing knowledge with data from New Approach Methodologies (NAMs) aiming to reduce or eliminate reliance on in vivo testing. Genotoxicity is particularly well‐suited for IATA development as numerous cutting‐edge, non‐animal methods have emerged in recent years, including 3D test systems, Prediscreen, MultiFlow, ToxTracker, and transcriptomic‐based biomarkers such as GENOMARK and TGx‐DDI. However, the integration of NAMs into IATAs must be systematic and scientifically robust. In this process, the Adverse Outcome Pathway (AOP) framework plays a crucial role by linking molecular‐level events to adverse health effects, thereby supporting the structured selection of NAMs. This article explores the key challenges and gaps within the current European regulatory frameworks for chemical compound genotoxicity assessment and discusses how an AOP‐based IATA can address these issues. Additionally, we present a global AOP network for permanent DNA damage, designed to guide IATA development and improve regulatory decision‐making. This integrated approach has the potential to enhance the accuracy, efficiency, and ethical standards of genotoxicity assessment while reducing reliance on animal testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Outcome PathwaysMutagensAnimalsHumansAnimal Testing AlternativesDNA DamageMutagenicity TestsRisk Assessment

Stichwörter der Autor:innen

AOPIATANAMsgenotoxicity

Substanzen

Mutagens

Autor:innen und Institutionen

  • Scientific Direction of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium.
  • Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
  • The Health Effects Laboratory, Department for Environmental Chemistry and Health Effects, The Climate and Environment Institute NILU, Kjeller, Norway.
  • Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy.
  • KWR Water Research Institute, Nieuwegein, the Netherlands.

ORCID-Profile: E Demuynck, T Vanhaecke, A Thienpont, D Cappoen, F Van Goethem, L M T Winkelman, J B Beltman, S Murugadoss, A-K Olsen, F Marcon, C Bossa, S M Shaikh, D Nikolopoulou, V Hatzi, J Pennings, M Luijten, C Adam-Guillermin, M Paparella, M Audebert, B Mertens

Förderung

  • The European Partnership for the Assessment of Risks from Chemicals (PARC)
  • European Union's Horizon Europe Research and Innovation Programme

Zitieren

APA

Demuynck, E., Vanhaecke, T., Thienpont, A., Cappoen, D., Van Goethem, F., Winkelman, L. M. T., Beltman, J. B., Murugadoss, S., Olsen, A. K., Marcon, F., Bossa, C., Shaikh, S. M., Nikolopoulou, D., Hatzi, V., Pennings, J., Luijten, M., Adam-Guillermin, C., Paparella, M., Audebert, M., & Mertens, B. (2025). Advancing Genotoxicity Assessment by Building a Global AOP Network. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.70022

Vancouver

Demuynck E, Vanhaecke T, Thienpont A, Cappoen D, Van Goethem F, Winkelman LMT, et al. Advancing Genotoxicity Assessment by Building a Global AOP Network. Environmental and Molecular Mutagenesis. 2025. doi:10.1002/em.70022

BibTeX
@article{Demuynck2025,
  author = {Demuynck, E and Vanhaecke, T and Thienpont, A and Cappoen, D and Van Goethem, F and Winkelman, L M T and Beltman, J B and Murugadoss, S and Olsen, A-K and Marcon, F and Bossa, C and Shaikh, S M and Nikolopoulou, D and Hatzi, V and Pennings, J and Luijten, M and Adam-Guillermin, C and Paparella, M and Audebert, M and Mertens, B},
  title = {Advancing Genotoxicity Assessment by Building a Global AOP Network},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2025},
  doi = {10.1002/em.70022}
}
Kostenlos starten →